We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Investigation of the Past 10 Yrs Health Care for Primary Care Patients With Chronic Obstructive Pulmonary Disease (PATHOS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01146392
First Posted: June 17, 2010
Last Update Posted: June 18, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
AstraZeneca
  Purpose
The aim of this study is to describe COPD health care and to assess demographics, concurrent diseases and mortality and the use of pharmaceuticals for a chronic obstructive pulmonary disease (COPD) population in real life in primary care during the last ten years.

Condition
Chronic Obstructive Pulmonary Disease

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: A Retrospective Epidemiological Study to Map Out Patients With Chronic Obstructive Pulmonary Disease (COPD) and Describe COPD Health Care in Real-Life Primary Care During the First Ten Years of the 21th Century

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Describe the development of COPD health care structure in primary care. [ Time Frame: Data will be extracted from the medical records on one occassion, covering a period of one decade. ]

Secondary Outcome Measures:
  • Describe the COPD population in primary care with special reference to treatment, co-morbidity and mortality during last decade. [ Time Frame: Data will be extracted from the medical records on one occassion, covering a period of one decade. ]

Enrollment: 27394
Study Start Date: June 2010
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Primary care patients with COPD diagnosis

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Eligible subjects are all COPD patients, found in medical records at the participating swedish primary care clinics. Primarily patients with diagnosis code J44 (ICD-10) stated in the medical record will be investigated. Patient data from the period 1 January 1999 - 31 December 2009 will be included in the observation.
Criteria

Inclusion Criteria:

  • COPD diagnosis according to medical records.
  • Use of drugs prescribed for obstructive lung diseases
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01146392


Locations
Sweden
Research Site
Uppsala, Sweden
Sponsors and Collaborators
AstraZeneca
Investigators
Principal Investigator: Docent Gunnar Johansson Uppsala University, Sweden
Study Chair: Kjell Larsson, Prof Karolinska Institutet
Study Director: Georgios Stratelis, MD AstraZeneca Nordics
  More Information

Additional Information:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: AstraZeneca
ClinicalTrials.gov Identifier: NCT01146392     History of Changes
Other Study ID Numbers: NIS-RSE-DUM-2010/1
First Submitted: June 16, 2010
First Posted: June 17, 2010
Last Update Posted: June 18, 2014
Last Verified: June 2014

Keywords provided by AstraZeneca:
Epidemiological
COPD health care
treatment in primary care

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases